[18F]FDG uptake and PCNA, Glut-1, and Hexokinase-II expressions in cancers and inflammatory lesions of the lung - Wikidata - wikimedia - TriplyDB

[18F]FDG uptake and PCNA, Glut-1, and Hexokinase-II expressions in cancers and inflammatory lesions of the lung

[18F]FDG uptake and PCNA, Glut-1, and Hexokinase-II expressions in cancers and inflammatory lesions of the lung

http://www.wikidata.org/entity/Q24550866

about

PET/CT imaging of Mycobacterium tuberculosis infection A review of the past, present, and future directions of neoplasia Neoplasia: Where We Have Been and Where We Are Going Therapeutically targeting cyclin D1 in primary tumors arising from loss of Ini1.Correlation of EGFR or KRAS mutation status with 18F-FDG uptake on PET-CT scan in lung adenocarcinoma.18F-FDG/18F-FES standardized uptake value ratio determined using PET predicts prognosis in uterine sarcoma.The role of metabolic tumor volume (MTV) measured by [18F] FDG PET/CT in predicting EGFR gene mutation status in non-small cell lung cancer Evaluation of 99mTc-3PRGD2 integrin receptor imaging in hepatocellular carcinoma tumour-bearing mice: comparison with 18F-FDG metabolic imaging.Specific biomarkers of receptors, pathways of inhibition and targeted therapies: clinical applications.Choline kinase alpha and hexokinase-2 protein expression in hepatocellular carcinoma: association with survival.Oncogene pathway activation in mammary tumors dictates FDG-PET uptake Evaluation of the factors affecting the maximum standardized uptake value of metastatic lymph nodes in different histological types of non-small cell lung cancer on PET-CT.Cancer stratification by molecular imaging.¹⁸F-fluoro-2-deoxyglucose uptake on PET CT and glucose transporter 1 expression in colorectal adenocarcinoma.Evaluation of efficacy of a new MEK inhibitor, RO4987655, in human tumor xenografts by [(18)F] FDG-PET imaging combined with proteomic approaches.The combination of the expression of hexokinase 2 and pyruvate kinase M2 is a prognostic marker in patients with pancreatic cancer.Dynamic FDG-PET Imaging to Differentiate Malignancies from Inflammation in Subcutaneous and In Situ Mouse Model for Non-Small Cell Lung Carcinoma (NSCLC).Added Value of Dual-Time-Point 18F-FDG PET/CT With Delayed Imaging for Detecting Aortic Graft Infection: An Observational Study.Long Term Prognostic Implications of Expression of Glucose Transporter-1 and Hexokinase II in Patients with Stage I Uterine Leiomyosarcoma.Epithelial and mesenchymal tumor compartments exhibit in vivo complementary patterns of vascular perfusion and glucose metabolism.Clinical significance of dual-time-point 18F-FDG PET imaging in resectable non-small cell lung cancer.Association between histopathological subtype, (18)F-fluorodeoxyglucose uptake and epidermal growth factor receptor mutations in lung adenocarcinoma.Glucose transporter-1 in pulmonary neuroendocrine carcinomas: expression and survival analysis.The correlation of SUVmax with pathological characteristics of primary tumor and the value of Tumor/ Lymph node SUVmax ratio for predicting metastasis to lymph nodes in resected NSCLC patients.Non-small cell lung cancer evaluated with quantitative contrast-enhanced CT and PET-CT: net enhancement and standardized uptake values are related to tumour size and histology.Apical and basolateral localisation of GLUT2 transporters in human lung epithelial cells.Advantages of L-3-[(18)F] fluoro-alpha-methyl tyrosine over 2-[(18)F]-fluoro-2-deoxyglucose in detecting liver metastasis during positron emission tomography scan.A false positive F-FDG PET/CT scan caused by breast silicone injection.Long-term prognostic implications and therapeutic target role of hexokinase II in patients with nasopharyngeal carcinoma 18F-fluorodeoxyglucose uptake in different histological subtypes of nasopharyngeal carcinoma.Characterization of progressive HIV-associated tuberculosis using 2-deoxy-2-[18F]fluoro-D-glucose positron emission and computed tomography.18F-FDG uptake in lung, breast, and colon cancers: molecular biology correlates and disease characterization The predictive value of 18F-FDG PET-CT for assessing the clinical outcomes in locally advanced NSCLC patients after a new induction treatment: low-dose fractionated radiotherapy with concurrent chemotherapy 18F-FLT and 18F-FDG PET-CT imaging in the evaluation of early therapeutic effects of chemotherapy on Walker 256 tumor-bearing rats.Analysis of 2-[Fluorine-18]-Fluoro-2-deoxy-D-glucose uptake kinetics in PET studies of pulmonary inflammation.Vascular imaging with positron emission tomography.A systemic review of PET and biology in lung cancer Imaging subclinical atherosclerosis: is it ready for prime time? A review.Accuracy of FDG-PET to diagnose lung cancer in areas with infectious lung disease: a meta-analysis.Regression of inflammation in atherosclerosis by the LXR agonist R211945: a noninvasive assessment and comparison with atorvastatin.

P2860

Q26748493-D602C51D-AB2A-4956-A717-43434280B4F9 Q28389391-E94EB070-7D03-433E-BC39-5460D670F25C Q28395095-3D5F913A-7580-4DB8-A135-C7A96C083172 Q30497840-2A3EF877-54EC-44C4-9951-E29990A1A709 Q33579714-A08CC169-369B-40BF-96AE-AB1CF98AC179 Q33618400-6CB116BD-63D9-4EAD-B9BD-391C789716CB Q33779663-B8AF57A8-3245-45AE-8F00-1F96CAFC66A9 Q33840534-82500B18-5790-48F6-BAEF-38F6E38BF3A2 Q34203953-661C3C75-3B13-4197-A966-8603A434C216 Q34447257-EF4B25F0-4817-436C-B648-7D104A5E0C59 Q35125252-3549BAD2-EDE8-438B-BBD3-00674D670BED Q35213647-F4B2BF0A-BACD-462E-903F-1C90CCE62D3F Q35380664-69889ABF-BB09-4328-A76B-ECDC786CA9AD Q35670459-A4EE32D1-A5EF-458C-93F3-720C783A5B37 Q35675442-A0D44448-3AE4-4687-9A9F-8128C679B391 Q35753643-8EE41221-6490-4D3A-93F4-2D460C9D757F Q35793481-569AB284-DA33-410D-BB1A-39238E76CE32 Q35857804-1F39983D-EEAB-4A07-A63F-E89F3B5D4E9C Q36001482-4D6023F9-1C38-496A-AA9D-A6DD3B18B456 Q36143593-CF9ED18D-EE0F-400E-928E-CF350B8306BA Q36337401-E52D31FB-73BB-446D-A620-780F4DC0AF91 Q36640546-7BCD09DD-36A0-4BFA-B70E-2AB1778DB93F Q36740205-180E032E-9E1B-4F96-B514-FEFBBB7746DF Q36755418-74D68F3C-34F2-4045-8880-AD0056756869 Q36773472-F64FBE07-98CD-42ED-9258-F6440F3C85A5 Q36784785-091CC55E-4224-4B9C-87D9-B692FFC3FE38 Q36910493-AD0BAE28-625B-474E-A483-1F73A068C7CE Q37118028-5781C4D9-C93C-4005-BB47-60FF927423E4 Q37225266-33CEAE2B-06D3-44FC-B139-92FA09C60A51 Q37290371-2BB34D16-6E2B-4F85-8CA6-407E7DF32B27 Q37322344-73C4F8DC-E5E5-4610-A463-4D1F5C85CDE5 Q37440346-9D363BC8-AAE0-4CF9-92A1-D661D5BA311D Q37566016-A914963D-A398-4AE9-B455-A6FFC3E856F2 Q37581739-16F6DF79-5D4B-4D54-A577-CDE54C08C500 Q37835530-768159C9-FED1-4F56-9F43-BFF240404334 Q37868709-5537C0A7-E076-4888-A503-4FF7AC43E875 Q37929599-D0AD25D5-699C-4E72-86FA-183FECC075A9 Q38239604-15022B7B-47D3-413D-8CE7-F0B502DEF9AB Q38253400-7D829892-1745-4974-AC74-767592D20AD7 Q38459399-2F488B50-48CA-4770-BC7E-FB03E92FBF1E

P2860

[18F]FDG uptake and PCNA, Glut-1, and Hexokinase-II expressions in cancers and inflammatory lesions of the lung

http://www.wikidata.org/entity/Q24550866

description

2005 nî lūn-bûn

@nan

2005 թուականի Ապրիլին հրատարակուած գիտական յօդուած

@hyw

2005 թվականի ապրիլին հրատարակված գիտական հոդված

@hy

2005年の論文

@ja

2005年論文

@yue

2005年論文

@zh-hant

2005年論文

@zh-hk

2005年論文

@zh-mo

2005年論文

@zh-tw

2005年论文

@wuu

name

[18F]FDG uptake and PCNA, Glut ...... flammatory lesions of the lung

@ast

[18F]FDG uptake and PCNA, Glut ...... flammatory lesions of the lung

@en

[18F]FDG uptake and PCNA, Glut ...... flammatory lesions of the lung

@nl

type

label

[18F]FDG uptake and PCNA, Glut ...... flammatory lesions of the lung

@ast

[18F]FDG uptake and PCNA, Glut ...... flammatory lesions of the lung

@en

[18F]FDG uptake and PCNA, Glut ...... flammatory lesions of the lung

@nl

prefLabel

[18F]FDG uptake and PCNA, Glut ...... flammatory lesions of the lung

@ast

[18F]FDG uptake and PCNA, Glut ...... flammatory lesions of the lung

@en

[18F]FDG uptake and PCNA, Glut ...... flammatory lesions of the lung

@nl

P1433

Q24550866-F83051C0-8827-4564-9418-233687648ADC

P1476

Q24550866-D6CE5218-D4A5-4512-BAAE-CE34C1265799

P2093

Q24550866-150C2DC4-BA14-4C42-9807-BF7051693961

Q24550866-1AF826BF-DA92-4905-B7FD-021C80EAE506

Q24550866-246CCEC6-50C7-42A6-A12A-5CA70EEC5F4C

Q24550866-45F1F723-299D-40F8-98C7-69A188D2F2C1

Q24550866-53989CE3-C64E-4A1F-915B-E40433E9AB1F

Q24550866-6159591F-D88B-4422-A961-F1C1C8FBF84D

Q24550866-7F530769-4424-4505-AC7C-48E2A6D860E9

Q24550866-804F46A1-02B6-49BC-8DF6-2E114E2DD2FF

Q24550866-90B6E2A8-EF11-4BA6-B2BD-A790E6833B47

Q24550866-A6830C24-DC9D-4D61-B546-5C148779BACB

P2860

Q24550866-0848E7EA-BBCD-45C9-BAD4-7C5AC0DC978B

Q24550866-08B1A154-0EA5-4558-8ECB-3E92ADD6D857

Q24550866-206E993F-16E4-4C34-9D71-C2F372BB1631

Q24550866-394410F9-2C68-4512-895B-72209C90AF0F

Q24550866-3CB1AAD9-3195-4201-A59E-142D06795BDA

Q24550866-4D7309B0-9DEF-4047-A859-FEC5D0379C42

Q24550866-51656975-34A0-4DDD-A409-DD7568494859

Q24550866-557F7CB3-CA07-4D57-BBD9-3C3838708314

Q24550866-5D2F0A39-CA77-4FD4-923C-9C879A608547

Q24550866-6B90ECB7-1199-4285-8675-6A9925AEC498

P304

Q24550866-F29C19C9-17B4-4BC9-90C6-8A8A676188C5

P31

Q24550866-36F21B7D-254B-49AE-BA86-1DA50C06E847

P3181

Q24550866-6681453C-0459-4B15-8870-E1D69E4A7BCD

P356

Q24550866-6EAA9E87-81B3-4046-A113-A67213E6C468

P407

Q24550866-AA88F167-75D9-46B8-9DDE-24E85B2FA89D

P433

Q24550866-64264475-63B8-4B9A-9A91-C866A4EEAE19

P478

Q24550866-9788D0D6-FC1C-4EA3-BAF8-F64651B06519

P577

Q24550866-E47CBBDF-D2F1-41BB-8B1F-E9A978A8CA90

P5875

Q24550866-91B04079-E3C6-4E00-9DB1-0FB7E9E54918

P698

Q24550866-D1484EC7-5B20-4BC1-9E89-F6FC62F11DE2

P921

Q24550866-F538D193-0CDC-4FAE-8DFC-4A0B7604FABD

P932

Q24550866-A544F143-E43B-4E41-8707-F37E36C3B082

P3181

P356

P1433

P1476

[18F]FDG uptake and PCNA, Glut ...... flammatory lesions of the lung

@en

P2093

Fumihiro Tanaka

http://www.w3.org/2001/XMLSchema#string

Hiromi Wada

http://www.w3.org/2001/XMLSchema#string

Kazuhiro Yanagihara

http://www.w3.org/2001/XMLSchema#string

Koichi Ishizu

http://www.w3.org/2001/XMLSchema#string

Marcelo Mamede

http://www.w3.org/2001/XMLSchema#string

Masanori Kitaichi

http://www.w3.org/2001/XMLSchema#string

Mio Li

http://www.w3.org/2001/XMLSchema#string

Takayoshi Ishimori

http://www.w3.org/2001/XMLSchema#string

Tatsuya Higashi

http://www.w3.org/2001/XMLSchema#string

Toshiaki Manabe

http://www.w3.org/2001/XMLSchema#string

P2860

Cancer statistics, 2004

Solitary pulmonary nodules: accuracy and cost-effectiveness of sodium iodide FDG-PET using Australian data.

Accuracy of positron emission tomography for diagnosis of pulmonary nodules and mass lesions: a meta-analysis.

Comparative efficacy of positron emission tomography with FDG and computed tomographic scanning in preoperative staging of non-small cell lung cancer.

Differential uptake of (18)F-fluorodeoxyglucose by experimental tumors xenografted into immunocompetent and immunodeficient mice and the effect of immunomodification.

Characterisation of macrophages infiltrating human mammary carcinomas.

Application of metabolic-control logic to fuel utilization and its significance in tumor cells.

Enzymology of cancer cells (first of two parts).

Facilitative glucose transporters.

Growth factors, mitogens, oncogenes and the regulation of glucose transport.

P304

369-79

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P3181

1639043

http://www.w3.org/2001/XMLSchema#string

P356

10.1593/NEO.04577

http://www.w3.org/2001/XMLSchema#string

P407

P433

4

http://www.w3.org/2001/XMLSchema#string

P478

7

http://www.w3.org/2001/XMLSchema#string

P577

2005-04-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

7776533

http://www.w3.org/2001/XMLSchema#string

P698

15967114

http://www.w3.org/2001/XMLSchema#string

P921

P932

1501150

http://www.w3.org/2001/XMLSchema#string